These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 16511435)

  • 1. Human placental transfer of atazanavir: a case report.
    Lechelt M; Lyons F; Clarke A; Magaya V; Issa R; de Ruiter A
    AIDS; 2006 Jan; 20(2):307. PubMed ID: 16511435
    [No Abstract]   [Full Text] [Related]  

  • 2. Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer.
    Ripamonti D; Cattaneo D; Maggiolo F; Airoldi M; Frigerio L; Bertuletti P; Ruggeri M; Suter F
    AIDS; 2007 Nov; 21(18):2409-15. PubMed ID: 18025877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atazanavir: a novel inhibitor of HIV-protease in haemodialysis.
    Izzedine H; Launay-Vacher V; Peytavin G; Valantin MA; Deray G
    Nephrol Dial Transplant; 2005 Apr; 20(4):852-3. PubMed ID: 15772278
    [No Abstract]   [Full Text] [Related]  

  • 4. The steady-state pharmacokinetics of atazanavir/ritonavir in HIV-1-infected adult outpatients is not affected by gender-related co-factors.
    von Hentig N; Babacan E; Lennemann T; Knecht G; Carlebach A; Harder S; Staszewski S; Haberl A
    J Antimicrob Chemother; 2008 Sep; 62(3):579-82. PubMed ID: 18477709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virological responses to atazanavir-ritonavir-based regimens: resistance-substitutions score and pharmacokinetic parameters (Reyaphar study).
    Pellegrin I; Breilh D; Ragnaud JM; Boucher S; Neau D; Fleury H; Schrive MH; Saux MC; Pellegrin JL; Lazaro E; Vray M
    Antivir Ther; 2006; 11(4):421-9. PubMed ID: 16856615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atazanavir and lopinavir with ritonavir alone or in combination: analysis of pharmacokinetic interaction and predictors of drug exposure.
    Di Giambenedetto S; De Luca A; Villani P; Bacarelli A; Ragazzoni E; Regazzi M; Cauda R; Navarra P
    HIV Med; 2008 Apr; 9(4):239-45. PubMed ID: 18366448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental transfer and pharmacokinetics of lopinavir and other protease inhibitors in combination with nevirapine at delivery.
    Gingelmaier A; Kurowski M; Kästner R; Eberle J; Mylonas I; Belohradsky BH; Friese K; Grubert TA
    AIDS; 2006 Aug; 20(13):1737-43. PubMed ID: 16931938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results.
    Gatell J; Salmon-Ceron D; Lazzarin A; Van Wijngaerden E; Antunes F; Leen C; Horban A; Wirtz V; Odeshoo L; Van den Dungen M; Gruber C; Ledesma E;
    Clin Infect Dis; 2007 Jun; 44(11):1484-92. PubMed ID: 17479947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual case of HIV virologic failure during treatment with boosted atazanavir.
    Duncan A; Mills J
    AIDS; 2013 May; 27(8):1361-2. PubMed ID: 23925384
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to Kourtis et al. 'Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis'.
    Townsend CL; Cortina-Borja M; Peckham CS; Tookey PA
    AIDS; 2007 Aug; 21(13):1831-2. PubMed ID: 17690590
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
    Nguyen ST; Eaton SA; Bain AM; Rahman AP; Payne KD; Bedimo R; Herrington JD; Maclayton DO; Rodriguez-Barradas MC; Busti AJ
    Pharmacotherapy; 2008 Mar; 28(3):323-30. PubMed ID: 18294112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atazanavir urolithiasis.
    Chang HR; Pella PM
    N Engl J Med; 2006 Nov; 355(20):2158-9. PubMed ID: 17108352
    [No Abstract]   [Full Text] [Related]  

  • 13. Methylmalonic acidaemia in a 7-month-old following maternal highly active antiretroviral therapy during pregnancy.
    Silf K; McMaster P; Hendriksz C
    AIDS; 2007 Aug; 21(13):1835-6. PubMed ID: 17690593
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis.
    Kourtis AP; Schmid CH; Jamieson DJ; Lau J
    AIDS; 2007 Mar; 21(5):607-15. PubMed ID: 17314523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplacental transfer of antiretroviral drugs and newborn birth weight in HIV-infected pregnant women.
    Ivanovic J; Nicastri E; Anceschi MM; Ascenzi P; Signore F; Pisani G; Vallone C; Mattia E; Notari S; Tempestilli M; Pucillo LP; Narciso P;
    Curr HIV Res; 2009 Nov; 7(6):620-5. PubMed ID: 19929798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case presentation: nephrolithiasis in a patient treated with atazanavir.
    Savini C; James C; Wilson S; Martin H; Szabo S; Scotto V
    J Assoc Nurses AIDS Care; 2008; 19(3):225-7. PubMed ID: 18457764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practice.
    Cleijsen RM; van de Ende ME; Kroon FP; Lunel FV; Koopmans PP; Gras L; de Wolf F; Burger DM
    J Antimicrob Chemother; 2007 Oct; 60(4):897-900. PubMed ID: 17704117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twins with cardiomyopathy and complete heart block born to an HIV-infected mother treated with HAART.
    Lopriore E; Rozendaal L; Gelinck LB; Bökenkamp R; Boelen CC; Walther FJ
    AIDS; 2007 Nov; 21(18):2564-5. PubMed ID: 18025905
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of concurrent administration of fosamprenavir and atazanavir without ritonavir in human immunodeficiency virus-negative subjects.
    McRae M; Clay PG; Anderson PL; Glaros AG
    Pharmacotherapy; 2009 Aug; 29(8):937-42. PubMed ID: 19637947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of baseline protease genotype and phenotype on HIV response to atazanavir/ritonavir in treatment-experienced patients.
    Naeger LK; Struble KA
    AIDS; 2006 Apr; 20(6):847-53. PubMed ID: 16549968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.